Company Encyclopedia
View More
name
Sabra Healthcare Reit
SBRA.US
As of September 30, 2025, Sabra's investment portfolio included 363 real estate properties held for investment (consisting of (i) 217 skilled nursing/transitional care facilities, (ii) 32 senior housing communities ("senior housing - leased"), (iii) 83 senior housing communities operated by third-party property managers pursuant to property management agreements ("senior housing - managed"), (iv) 16 behavioral health facilities and (v) 15 specialty hospitals and other facilities), 14 investments in loans receivable (consisting of three mortgage loans and 11 other loans), four preferred equity investments and two investments in unconsolidated joint ventures. As of September 30, 2025, Sabra's real estate properties held for investment included 36,998 beds/units, spread across the United States and Canada.
1.412 T
SBRA.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Equity Real Estate Investment Trusts (REITs)Industry
Industry Ranking51/164
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE6.29%C
    • Profit Margin23.44%A
    • Gross Margin63.71%A
  • Growth ScoreB
    • Revenue YoY9.34%B
    • Net Profit YoY80.17%A
    • Total Assets YoY3.70%C
    • Net Assets YoY2.99%C
  • Cash ScoreC
    • Cash Flow Margin426.70%C
    • OCF YoY9.34%B
  • Operating ScoreE
    • Turnover0.14E
  • Debt ScoreC
    • Gearing Ratio49.20%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Evaluating Sabra Health Care REIT (SBRA) Valuation Following Recent 6% Share Price Gain

    Sabra Health Care REIT (SBRA) has seen a 6% share price increase, prompting investors to reassess its valuation. Despite trading below analyst price targets, Sabra shows strong returns, with a fair value estimated at $20.82, suggesting it is undervalued. The REIT benefits from high demand for senior housing, but faces risks from regulatory pressures and new operator challenges. Investors are encouraged to explore further opportunities in undervalued stocks and dividend yields.

    Simplywall·
    US
    SBRA
    -0.88%
    Simplywall·
    US
    SBRA
    -0.88%

    Sabra Health Care REIT Reports Strong Q3 2025 Results

    Sabra Health Care REIT (SBRA) reported strong Q3 2025 results, with net income of $0.09 per diluted share and FFO of $0.33. The company achieved a 13.3% year-over-year increase in same-store managed senior housing cash NOI and made significant acquisitions worth $217.5 million. Sabra issued 9.6 million shares, raising $165.0 million, and received a credit rating upgrade to 'Baa3' from Moody’s. The company updated its 2025 earnings guidance, projecting net income per share between $0.655 and $0.665, while focusing on expanding its senior housing portfolio.

    Tip Ranks·
    US
    SBRA
    -0.88%
    Tip Ranks·
    US
    SBRA
    -0.88%

    Sabra Healthcare REIT’s Optimistic Earnings Call Analysis

    Sabra Healthcare REIT's Q3 earnings call highlighted a cautiously optimistic outlook, showcasing strong growth in its SHOP portfolio, which now comprises 26% of total assets, with a target to reach 40%. Financial metrics were robust, with a 15.9% cash NOI growth. However, challenges included decreased cash rental income and increased borrowing costs. Moody's upgraded Sabra's credit rating to Baa3, reflecting confidence in future earnings. The company exceeded its investment target, closing over $550 million in deals for 2025, while acknowledging concerns in the Holiday properties segment. Overall, Sabra is strategically positioned for future growth despite current challenges.

    Tip Ranks·
    US
    SBRA
    -0.88%
    Tip Ranks·
    US
    SBRA
    -0.88%

    Sabra Healthcare REIT: Balancing Strong FAD Performance with Capital Cost Challenges

    Juan C. Sanabria has assigned a Hold rating to Sabra Healthcare REIT, citing mixed performance in its third-quarter 2025 funds available for distribution (FAD) and funds from operations (FFO). While FAD exceeded expectations, FFO fell short. The company maintains a stable outlook with FAD guidance above market predictions, but faces challenges with capital costs reflected in its valuation metrics. Despite strong acquisition activity, these financial constraints may limit growth potential. Sanabria is a 2-star analyst with a 0.5% average return and a 45.73% success rate, covering the Real Estate sector.

    Tip Ranks·
    US
    SBRA
    -0.88%
    Tip Ranks·
    US
    SBRA
    -0.88%

    Sabra Healthcare REIT Reports Q3 Results and Upgraded Rating

    Sabra Healthcare REIT (SBRA) reported Q3 results with a net income of $0.09 per diluted share and a 13.3% increase in same-store managed senior housing Cash NOI year-over-year. The company raised $165 million through share issuance and received a Moody’s upgrade to ‘Baa3’ for its senior unsecured notes. Sabra updated its 2025 earnings guidance, projecting growth in its managed senior housing portfolio. Analysts rate SBRA stock as a Buy with a $20.00 price target, highlighting strong financial performance but noting some technical risks.

    Tip Ranks·
    US
    SBRA
    -0.88%
    Tip Ranks·
    US
    SBRA
    -0.88%
    © 2025 Longbridge｜Disclaimer